InvestorsObserver
×
News Home

Is Price of INO Stock Justified by its Earnings?

Friday, July 10, 2020 03:25 PM | InvestorsObserver Analysts

Mentioned in this article

Is Price of INO Stock Justified by its Earnings?

The 94 rating InvestorsObserver gives to Inovio Pharmaceuticals Inc (INO) stock puts it near the top of the Healthcare sector.

In addition to scoring higher than 83 percent of stocks in the Healthcare sector, INO’s 94 overall rating means the stock scores better than 94 of all stocks.

Overall Score - 94
INO has an Overall Score of 94. Find out what this means to you and get the rest of the rankings on INO!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease.

These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Inovio Pharmaceuticals Inc Stock Today?

Inovio Pharmaceuticals Inc (INO) stock is trading at $23.30 as of 3:17 PM on Friday, Jul 10, a rise of $0.03, or 0.13% from the previous closing price of $23.27. Volume today is below average. So far 14,718,118 shares have traded compared to average volume of 45,653,393 shares. The stock has traded between $22.65 and $23.65 so far today.

To screen for more stocks like INO click here.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App